ROCK HILL, SC, Sept. 12, 2022 (GLOBE NEWSWIRE) — Today, 3D systems (NYSE:DDD) announced that Andrew Johnson, the company’s executive vice president and chief legal officer, is taking on expanded responsibilities as chief business development officer. In this role, he will not only lead the company’s mergers and acquisitions, but will also lead the establishment of new strategic partnerships in support of the company’s growing business needs. Mr. Johnson has been with 3D Systems for over 16 years and during that time has led over 60 M&A transactions for the company and played a key role in the development of several strategic partnerships. His strategic vision, experience and knowledge of the additive manufacturing industry make him well placed to take on this expanded responsibility as Chief Business Development Officer, in addition to his current role as Chief Legal Officer. Mr. Johnson holds a BA from the University of Miami, an MBA from the Ross School of Business at the University of Michigan and a JD from the University of Virginia.
“Our core strength as a company, the one that differentiates us from our competitors, is our consistent focus on applications to solve our customers’ most important challenges,” said Dr. Jeffrey Graves, President and CEO. from 3D Systems. “To be effective in this approach, it is essential for us to be the leader in the implementation of a wide range of basic printing technologies, from metals to polymers and biologics, in combination with materials and market-leading software solutions. To do this on an ever-increasing scale, we must increasingly seek out strategic partnerships, ranging from core technology to commercial channels to market. This activity is key to taking advantage of the full range of exciting opportunities that are opening up before us as additive manufacturing enters large-scale production environments. Andy’s experience and knowledge of our business and the industry overall positions him very well to succeed in this expanded role.
Mr. Johnson’s responsibilities will span all of the company’s interests. One of the key emerging areas he will discuss is the growing partnership opportunities that 3D Systems now has in the field of regenerative medicine. With technical advancements made by 3D Systems’ Regenerative Medicine team, led by Chuck Hull, CTO for Regenerative Medicine, and in partnership with United Therapeutics, as well as acquisitions of Allevi and Volumetric Biotechnologies , the company has unique capabilities that are needed to pursue an increasing number of new biological applications. To capitalize on this potential, Mr. Johnson will explore application partnerships that could accelerate the company’s growth in these new and exciting markets.
Certain statements made in this release that are not statements of historical or current fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by words such as “believes”, “believes”, “expects”, “may”, “will”, “estimates”, “intends”. , “anticipate” or “plan” or the negative of these terms or other comparable terms. Forward-looking statements are based on management’s current beliefs, assumptions and expectations and may include comments about the company’s beliefs and expectations regarding future events and trends affecting its business and are necessarily subject to uncertainties, including many are beyond the company’s control. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or anticipated in the forward-looking statements. research statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, the forward-looking statements are not and should not be taken as guarantees of future performance or results, and they will not necessarily prove to be precise indications of time at which these performances or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by or on behalf of management, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law. requires it.
About 3D Systems
Over 35 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance and reliability to every interaction – enabling our customers to create products and business models never before possible. With our unique offering of hardware, software, materials and services, each application-specific solution is powered by the expertise of our application engineers who work with customers to transform the way they deliver their products and services. 3D Systems’ solutions serve a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace and defense, automotive, and durable goods. More information about the company is available at www.3dsystems.com.
A photo accompanying this ad is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b20070fd-a0ac-4f23-93a9-4aba4540cad5
Copyright 2022 GlobeNewswire, Inc.